Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics

Life Sci. 1982 Jan 18;30(3):229-34. doi: 10.1016/0024-3205(82)90503-3.

Abstract

Administration of estrogen to rats during the period of withdrawal from chronic haloperidol attenuated the characteristic increase in apomorphine-induced stereotypy and the increase in (3H) spiroperidol binding. This apparent ability of estrogen to "down-regulate" brain dopamine receptors could lead to useful pharmacological treatments of tardive dyskinesia and possibly of other hyperdopaminergic states.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Drug Administration Schedule
  • Estradiol / metabolism*
  • Female
  • Haloperidol / metabolism
  • Humans
  • In Vitro Techniques
  • Radioligand Assay
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / metabolism*
  • Spiperone / metabolism
  • Stereotyped Behavior

Substances

  • Receptors, Dopamine
  • Estradiol
  • Spiperone
  • Haloperidol
  • Apomorphine